Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

11/08/2021 05:40

Aug 11 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.60               12.43            48.50    
                 (+1.4 pct)          (+5.8 pct)       (-1.5 pct)  
  Operating        612 mln             967 mln            1.20    
                 (-36.7 pct)        (+101.0 pct)      (-49.0 pct) 
  Recurring        780 mln               1.01             1.10    
                 (-22.7 pct)         (+68.8 pct)      (-50.6 pct) 
  Net              547 mln             721 mln          700 mln   
                 (-24.1 pct)         (+75.8 pct)      (-56.4 pct) 
  EPS             62.45 yen           82.26 yen        79.78 yen  
  Ann Div                             60.00 yen        60.00 yen  
  -Q2 div                             30.00 yen        30.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T